Lifeward Ltd. 8-K

What Happened
Lifeward Ltd. announced results of its Extraordinary General Meeting held January 6, 2026. Shareholders approved three proposals: (1) authorize the Board to decide whether to effect a reverse share split of outstanding ordinary shares at a ratio between 1-for-2 and 1-for-12 and to amend the articles to reflect any split; (2) if a reverse split is effected, approve an increase in the company’s authorized share capital; and (3) eliminate the par value of the company’s ordinary shares. The record date for the meeting was November 26, 2025; 7,620,593 shares (≈41.7% of 18,293,776 outstanding) were present or voted, constituting a quorum. (See Definitive Proxy on Schedule 14A filed December 1, 2025.)

Key Details

• Meeting date: January 6, 2026; record date: November 26, 2025.
• Shares present/voted: 7,620,593 (≈41.7% of 18,293,776 outstanding).
• Proposal 1 (authorize reverse split 1-for-2 to 1-for-12): For 5,473,874; Against 2,084,129; Abstain 62,589. (~71.8% For of shares voting).
• Proposal 2 (authorize increase in authorized share capital, contingent on split): For 5,343,641; Against 2,149,990; Abstain 126,960. (~70.1% For).
• Proposal 3 (eliminate par value): For 5,037,563; Against 1,506,673; Abstain 1,076,355. (~66.1% For; notable abstentions).

Why It Matters
The votes authorize Lifeward’s Board to decide whether to implement a reverse share split (including the split ratio and timing) and to make related charter changes. If the Board implements a reverse split, the number of outstanding shares would be reduced and the per-share price would increase proportionally; the Board has not yet decided to implement it. Approval to increase authorized share capital and eliminate par value are charter-level changes that enable future corporate actions (such as issuance of additional shares) and update share structure mechanics. Investors should note these approvals are authorizations only — any actual reverse split or share issuances would be announced separately.